A controlled trial of azathioprine in Behçet's syndrome.
about
Interventions for the management of oral ulcers in Behçet's diseaseEmerging drugs for uveitisClinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndromeHuman recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitisBehçet's disease: a new target for anti-tumour necrosis factor treatmentIntestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?A Clinical Picture of the Visual Outcome in Adamantiades-Behçet's DiseaseMucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future PerspectivesA double-blind trial of colchicine in Behçet's syndromeA double-blind trial of depot corticosteroids in Behçet's syndromeOcular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.Behçet's Uveitis.Ocular and neurological Behçet's disease without orogenital ulceration?Gender Differences in Behçet's Disease Associated Uveitis.Severe atypical Behçet's syndrome.Current approach in the diagnosis and management of panuveitis.Biological treatments in Behçet's disease: beyond anti-TNF therapy.Novel approaches to Behçet's disease.Diagnosis and treatment of cerebral vasculitis.Pharmacotherapy for uveitis: current management and emerging therapy.The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.Behcet's Syndrome.Treatment of vasculitis.The treatment of chronic recurrent oral aphthous ulcers.Developments in the treatment of uveitis.Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.Treatment of neuro-Behçet's disease: an update.Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease.Behçet's Syndrome and ThrombosisNew Evidence-Based Treatment Approach in Behçet's Disease.Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye diseasePars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations.Outcome measures used in clinical trials for Behçet syndrome: a systematic review.Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.Morbus Behçet - a rare disease in Central Europe.Retrospective study on the effects of immunosuppressive therapy in uveitis associated with rheumatic diseases in Korea.Immunosuppressive therapy in autoimmune disease--a review.Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.Mucocutaneous lesions of Behcet's disease
P2860
Q24193450-CC7F4EE8-3BBF-4F04-9BF9-D13C4EBB67AEQ24630848-7B30304E-94BA-42CC-BCF9-263576833EB2Q24654208-E2DEA828-1CD5-45A6-BD33-EAFC9F0A88F5Q24671749-17B3E781-6AE5-4346-9B37-6AC0335B14FEQ24675071-519BDA63-75F7-465F-B341-1443F3ECA970Q26775240-B045098F-12D7-4AFE-8D10-D4B449BE9AD4Q26777598-E544F51C-0D4A-4415-9E70-9F73FE560CD5Q26799767-7C2E7044-D8F5-4A73-A92E-D2F3F1BDCA79Q28205622-9A6CE8DB-644A-4FE0-BE9D-B62573371D27Q28279953-9D55F07D-94C4-4AF2-9506-8E181779D90AQ33360668-769B8CD9-B820-4047-91E1-E0899D1B015CQ33559788-634AB325-109C-4656-AF0A-43981655BB9DQ33591149-4DE9ACB6-F827-493E-9D8B-AB1B0BE4696CQ33597470-19937896-B19F-48E3-AE61-2721A1307A37Q33607292-EA31C834-F130-422B-8E85-B550DC31ABDEQ33737954-591CC287-08E4-4A95-848F-6EB2C18CE489Q33908217-656898AB-DACE-4E67-ABE5-CAD7B884D252Q34075044-DD696046-060E-4469-AB11-AFE504464F3EQ34156332-10109A10-0450-40A2-A32D-67CFE54FFCCDQ34274075-4C549BD7-967F-43EC-B8D7-17128991D80AQ34286402-A3C1007F-525D-4315-A4D4-5B35205854C3Q34311953-7623E462-46AF-4EF9-A6B5-DF09255D896BQ34403507-0B36789E-03E1-480F-80A7-83FEB7B05046Q34430267-6A116EC8-F714-48A8-B3CC-C0F04B169422Q34481964-AE0AE331-AE2D-4813-9E4A-115E7C347C85Q34530196-1FF13AA6-DCF4-4316-A0A1-DA322932C0CBQ34974052-EE8C774F-93A3-455D-B160-ADB3EE0C75CEQ35001001-EF3706D3-B138-4A8A-B499-BB68F9614BC3Q35153639-3917C344-96BC-4127-A5A8-9D316551AEA0Q35295186-551660D8-C385-4BE1-85AE-BE10645F5F05Q35305133-6346E787-3430-4A92-BC12-B549B806E946Q35762819-6ABBAA1A-A413-4D8A-B31B-1B573F221838Q35763093-F418F84B-1064-4671-A62B-3310051ADDAFQ35868282-E57D13F9-0FF3-4396-925A-A990748D5FC4Q36371451-8E81EE2D-960D-489E-94FE-156F4D4080ADQ36418989-2EF5EF49-46D8-44B7-8660-07F69B9EB8DCQ36420772-96CAB6A0-6AC5-4A89-9BC8-4296E4845068Q36850438-87D16B27-B0CC-463D-B597-FCFC30C3A690Q36891665-7E35804E-14E5-4F3A-BBF8-27866B04A5F1Q36920297-E8D619A3-2F14-4331-8459-032711EF3D71
P2860
A controlled trial of azathioprine in Behçet's syndrome.
description
1990 nî lūn-bûn
@nan
1990 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
A controlled trial of azathioprine in Behçet's syndrome.
@ast
A controlled trial of azathioprine in Behçet's syndrome.
@en
A controlled trial of azathioprine in Behçet's syndrome.
@nl
type
label
A controlled trial of azathioprine in Behçet's syndrome.
@ast
A controlled trial of azathioprine in Behçet's syndrome.
@en
A controlled trial of azathioprine in Behçet's syndrome.
@nl
prefLabel
A controlled trial of azathioprine in Behçet's syndrome.
@ast
A controlled trial of azathioprine in Behçet's syndrome.
@en
A controlled trial of azathioprine in Behçet's syndrome.
@nl
P2093
P1476
A controlled trial of azathioprine in Behçet's syndrome.
@en
P2093
Ozyazgan Y
Serdaroğlu S
Yurdakul S
P304
P356
10.1056/NEJM199002013220501
P407
P577
1990-02-01T00:00:00Z